You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Arcellx
since
auto-detected in 2 stories
4 days ago
These are the stocks posting the largest moves in premarket trading.
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion ⊖⊖
Gilead Sciences said on Monday it will buy cancer therapy partner Arcellx for an implied equity value of $7.8 billion.
page 1 of 1